Richard Franklin
15Patents
2h-index
4Co-inventors
47Inventor score
Filing activity: Mar 25, 1981 → May 25, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| USD851657S1 | Display screen with transitional graphical user interface | General | 29 | Active |
| US8633158B1 | Angiotensin in treating brain conditions | Chemistry; Metallurgy | 10 | Active |
| USD877764S1 | Display screen with transitional graphical user interface | General | 2 | Active |
| US7910597B2 | Substituted quinazolines | Human Necessities | 1 | Active |
| US4385059A | Thiazole compositions | Chemistry; Metallurgy | 1 | Expired |
| US7700608B2 | Quinazoline derivatives and their use in the treatment of thrombocythemia | Chemistry; Metallurgy | 1 | Active |
| US9511055B2 | Angiotensin in treating brain conditions | Chemistry; Metallurgy | 0 | Active |
| US10973869B2 | Methods of treating cardiomyopathy associated with genetic disorders | Human Necessities | 0 | Active |
| US9333233B2 | Methods and compositions for the delayed treatment of stroke | Human Necessities | 0 | Active |
| US10960045B2 | Methods and compositions for the treatment of epidermolysis bullosa | Human Necessities | 0 | Active |
| US9133241B2 | Peptide compositions | Human Necessities | 0 | Active |
| US8557958B1 | Compositions and methods for treatment of diabetes | Chemistry; Metallurgy | 0 | Active |
| US9107870B2 | Angiotensin peptides in treating marfan syndrome and related disorders | Human Necessities | 0 | Active |
| US11324746B2 | Use of anagrelide for treating cancer | Human Necessities | 0 | Active |
| US8304420B2 | Substituted quinazolines for reducing platelet count | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.